These results imply that PES1 regulates several necessary functional oncogenic modules in tumors and that PES1 proteins or transcripts are involved in regulating the potential immunogenicity and immunotherapeutic effects of various cancers, thus promoting tumor patient progression and reducing prognosis. The gene discussed is PES1; the disease is neoplasm.